Molecular Partners AG
Stock Forecast, Prediction & Price Target
Molecular Partners AG Financial Estimates
Molecular Partners AG Revenue Estimates
Molecular Partners AG EBITDA Estimates
Molecular Partners AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF9.33M N/A | CHF189.55M 1931.68% | CHF7.03M -96.28% | Avg: CHF18.5M Low: CHF18.5M High: CHF18.5M avg. 162.85% | Avg: CHF18M Low: CHF18M High: CHF18M avg. -2.70% | Avg: CHF75M Low: CHF75M High: CHF75M avg. 316.66% | Avg: CHF120M Low: CHF120M High: CHF120M avg. 60% |
Net Income
% change YoY
| CHF-63.78M N/A | CHF117.85M 284.76% | CHF-61.98M -152.59% | Avg: CHF-66.96M Low: CHF-66.96M High: CHF-66.96M avg. -8.02% | Avg: CHF-75.48M Low: CHF-75.48M High: CHF-75.48M avg. -12.72% | Avg: CHF-67.17M Low: CHF-67.17M High: CHF-67.17M avg. 10.99% | Avg: CHF-47.51M Low: CHF-47.51M High: CHF-47.51M avg. 29.26% |
EBITDA
% change YoY
| CHF-60.76M N/A | CHF120.12M 297.70% | CHF-59.51M -149.54% | Avg: CHF-12.45M Low: CHF-12.45M High: CHF-12.45M avg. 79.07% | Avg: CHF-12.11M Low: CHF-12.11M High: CHF-12.11M avg. 2.70% | Avg: CHF-50.49M Low: CHF-50.49M High: CHF-50.49M avg. -316.66% | Avg: CHF-80.79M Low: CHF-80.79M High: CHF-80.79M avg. -59.99% |
EPS
% change YoY
| -$2.06 N/A | $3.63 276.21% | -$1.89 -152.06% | Avg: -$2.04 Low: -$2.04 High: -$2.04 avg. -8.11% | Avg: -$2.3 Low: -$2.3 High: -$2.3 avg. -12.72% | Avg: -$2.05 Low: -$2.05 High: -$2.05 avg. 10.99% | Avg: -$1.45 Low: -$1.45 High: -$1.45 avg. 29.26% |
Operating Expenses
% change YoY
| CHF72.74M N/A | CHF72.94M 0.26% | CHF20.30M -72.16% | Avg: CHF23.87M Low: CHF23.87M High: CHF23.87M avg. 17.58% | Avg: CHF23.22M Low: CHF23.22M High: CHF23.22M avg. -2.70% | Avg: CHF96.77M Low: CHF96.77M High: CHF96.77M avg. 316.66% | Avg: CHF154.84M Low: CHF154.84M High: CHF154.84M avg. 60.00% |
FAQ
What is Molecular Partners AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.87% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -66.96M, average is -66.96M and high is -66.96M.
What is Molecular Partners AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 134.20% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is CHF18.5M, average is CHF18.5M and high is CHF18.5M.
What is Molecular Partners AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 4.85% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$2.04, average is -$2.04 and high is CHF-2.04.